Clinical Trial Update: The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging [NA]

View source ↗

Summary

A clinical trial is evaluating Gallium-68 NOTA-DNA multivalent SGC8 as an imaging agent for bladder tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Gallium-68 NOTA-DNA multivalent SGC8 injection

Snippet

Sponsor: RenJi Hospital | Conditions: Bladder Cancer | NA | Status: RECRUITING